Park Avenue Securities’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$680K	Buy	+2,085	New	+$680K	0.01%	927
2025 Q1	–	Sell	-1,368	Closed	-$322K	–	1169
2024 Q4	$322K	Buy	1,368 +538	+65%	+$127K	﹤0.01%	1260
2024 Q3	$228K	Buy	+830	New	+$228K	﹤0.01%	1295